Afya Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Afya wird ein jährliches Gewinn- und Umsatzwachstum von 21.6% bzw. 9.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 22.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 21.1% betragen.

Wichtige Informationen

21.6%

Wachstumsrate der Gewinne

22.9%

EPS-Wachstumsrate

Consumer Services Gewinnwachstum	24.5%
Wachstumsrate der Einnahmen	9.7%
Zukünftige Eigenkapitalrendite	21.1%
Analystenabdeckung	Good
Zuletzt aktualisiert	20 Dec 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Aug 29

Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Aug 29

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Aug 15

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Jul 17

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 20

Afya's Results Are Improving And The Market Is Undervaluing It

Jun 06

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

May 14

AFYA: Mr Market Is Mistaken

Apr 29

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Apr 27

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Apr 09

Afya Is Performing Well And Is A Buy

Mar 19

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Mar 17

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Feb 10

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Jan 21

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Jan 03

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Dec 07

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Nov 02

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Sep 20

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Aug 17

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Aug 23

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Jul 28

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Apr 14

Afya On A Grey Price Area

Dec 25

Afya: The Longer-Term Growth Story Remains Intact

Sep 19

Afya to acquire UNIGRANRIO for R$700M

May 27

Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

Apr 04

Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Mar 09

Is Afya (NASDAQ:AFYA) Using Too Much Debt?

Feb 16

A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

Jan 29

The Trends At Afya (NASDAQ:AFYA) That You Should Know About

Jan 12

What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 24

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:AFYA - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (BRL Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	3,983	949	1,227	1,376	7
12/31/2025	3,678	769	1,131	1,159	8
12/31/2024	3,291	650	929	1,010	8
9/30/2024	3,185	580	889	1,296	N/A
6/30/2024	3,067	553	893	1,173	N/A
3/31/2024	2,970	478	838	1,130	N/A
12/31/2023	2,876	386	798	1,044	N/A
9/30/2023	2,730	355	759	1,024	N/A
6/30/2023	2,587	337	667	953	N/A
3/31/2023	2,473	356	606	897	N/A
12/31/2022	2,329	374	547	844	N/A
9/30/2022	2,243	352	495	818	N/A
6/30/2022	2,117	329	430	738	N/A
3/31/2022	1,891	245	434	730	N/A
12/31/2021	1,719	223	354	631	N/A
9/30/2021	1,566	235	387	591	N/A
6/30/2021	1,421	257	329	503	N/A
3/31/2021	1,323	300	300	449	N/A
12/31/2020	1,201	292	234	372	N/A
9/30/2020	1,077	285	283	377	N/A
6/30/2020	974	257	234	380	N/A
3/31/2020	878	212	210	343	N/A
12/31/2019	751	154	178	299	N/A
9/30/2019	636	128	137	247	N/A
6/30/2019	522	106	119	156	N/A
3/31/2019	417	110	93	120	N/A
12/31/2018	334	86	59	80	N/A
12/31/2017	216	45	N/A	40	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: AFYADas prognostizierte Gewinnwachstum (21.6% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: AFYADie Erträge des Unternehmens (21.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.2% pro Jahr).

Hohe Wachstumserträge: AFYAEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: AFYADie Einnahmen des Unternehmens (9.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (9.1% pro Jahr).

Hohe Wachstumseinnahmen: AFYADie Einnahmen des Unternehmens (9.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: AFYADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (21.1%)

Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2024/12/22 16:53
Aktienkurs zum Tagesende	2024/12/20 00:00
Gewinne	2024/09/30
Jährliche Einnahmen	2023/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

^* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie hier mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf .

Analysten-Quellen

Afya Limited wird von 15 Analysten beobachtet. 8 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
Fred Mendes	BofA Global Research
Flavio Yoshida	BofA Global Research
Marcio Osako	Bradesco S.A. Corretora de Títulos e Valores Mobiliários

Afya Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Afya Limited Reaffirms Financial Guidance for the Year 2024

Afya Limited Updates Financial Guidance for the Year 2024

Afya Limited Provides Earnings Guidance for the FY2024

Consensus EPS estimates fall by 14%

Consensus EPS estimates increase by 11%

Consensus EPS estimates increase by 12%

Recent updates

Should You Be Adding Afya (NASDAQ:AFYA) To Your Watchlist Today?

Afya Continues To Be An Opportunity Even After Brazil's Depreciation

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Third quarter 2024 earnings: EPS misses analyst expectations

Afya Limited Reaffirms Financial Guidance for the Year 2024

Investors Holding Back On Afya Limited (NASDAQ:AFYA)

Returns At Afya (NASDAQ:AFYA) Are On The Way Up

Afya Limited to Report Q3, 2024 Results on Nov 13, 2024

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Second quarter 2024 earnings: EPS exceeds analyst expectations

Afya Limited Updates Financial Guidance for the Year 2024

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Afya Limited to Report Q2, 2024 Results on Aug 14, 2024

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Limited Announces the Resignation of Shobhna Mohn as a Member of the Board of Directors

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Afya's Results Are Improving And The Market Is Undervaluing It

Afya Limited, Annual General Meeting, Jun 05, 2024

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024

Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

AFYA: Mr Market Is Mistaken

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Full year 2023 earnings: EPS misses analyst expectations

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Afya Limited Provides Earnings Guidance for the FY2024

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Afya Limited to Report Q4, 2023 Results on Mar 14, 2024

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Consensus EPS estimates fall by 14%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Consensus EPS estimates increase by 11%

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Afya Limited to Report Q3, 2023 Results on Nov 13, 2023

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya Limited to Report Q2, 2023 Results on Aug 28, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Afya Limited to Report Q1, 2023 Results on May 24, 2023

Afya Limited, Annual General Meeting, Jun 15, 2023

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates increase by 12%

Afya Announces Changes to Its Board of Directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Investor sentiment improved over the past week

Afya Limited to Report Q3, 2022 Results on Nov 21, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Investor sentiment improved over the past week

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Afya Limited to Report Q2, 2022 Results on Aug 22, 2022

Consensus forecasts updated

First quarter 2022 earnings: EPS exceeds analyst expectations

Investor sentiment deteriorated over the past week

Erste Wv GÜTersloh Gmbh signed a basic agreement to acquire additional 2.4% stake in Afya Limited (NasdaqGS:AFYA) from Nicolau Carvalho Esteves Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd.

Less than half of directors are independent

Afya Limited Announces Changes to its Board of Directors

Afya Limited to Report Q1, 2022 Results on May 23, 2022

Afya Limited, Annual General Meeting, Apr 29, 2022

Afya: Margin And Organic Growth Struggles Remain Top Of Mind